Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

DAS — Predicate Candidate Screening

8 FDA 510(k) clearances under this product code; the 50 most recent screened below.

73 daysmedian FDA review time
132 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K982023PELICALSS HUMAN IGG SUBCLASS NEPHLOMETRIC ARRAY KITInova Diagnostics, Inc.1998-09-04870
K944876HUMAN IGG SUBCLASSES NEPHELOMETRIC BNA KITResearch Diagnostics, Inc.1994-12-15730
K943098HUMAN IGG SUBCLASSES ELISA COMBI KITResearch Diagnostics, Inc.1994-09-07710
K943205HUMAN IGG SUBCLASSES RID COMBI KIT (MODIFICATION)Research Diagnostics, Inc.1994-09-07640
K895600HUMAN (IGG) SUBCLASS (EIA) KITThe Binding Site, Ltd.1989-11-08510
K790708ANTISERUM TO HUMAN IG G FC FRAGMENTSKent Laboratories, Inc.1979-08-221320
K790715ANTISERUM TO HUMAN FCKent Laboratories, Inc.1979-08-161260
K761156AMINOGLYCOSIDE CONTROLSSupelco, Inc.1976-12-09100

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda